None listed
Conditions
Interventions
Thoracic and abdominal endoscopic operation group:The abdominal endoscopic surgical system independently developed by Ruilonofu (Shanghai) Medical Technology Co., Ltd. is used for endoscopic surgery i
Sponsors
Affiliated Cancer Hospital of Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1)18 years old = age =80 years old, gender is not limited; 2) Plans to perform urology, gynecology, general surgery or thoracic surgery laparoscopic surgery system to assist laparoscopic or thoracoscopic surgery; 3) Agree to participate in this study, and voluntarily sign the informed consent; 4) Willing to cooperate to complete the study follow-up and related examinations.
Exclusion criteria
Exclusion criteria: 1) BMI < 18.5kg/m^2 or BMI=30kg/m^2; 2) Patients with severe cardiovascular diseases who cannot tolerate laparoscopic thoracic surgery; 3) Patients with severe respiratory diseases who cannot tolerate laparoscopic thoracic surgery; 4) Patients with severe coagulation dysfunction who cannot tolerate laparoscopic thoracic surgery; 5) Patients with a history of thoracic, abdominal and pelvic surgery or chemoradiotherapy are not suitable for thoracic laparoscopic surgery; 6) Pregnant and lactating women; 7) Patients who are participating in clinical trials of other drugs or medical devices; 8) Patients considered unsuitable for this study by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical failure rate;Serious complication rate of surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| System preparation time;Robot-assisted surgery time;Device performance evaluation;Intraoperative physiological load evaluation by the surgeon during surgery;Evaluation of the mental load of the surgeon during surgery;Postoperative hospital stay;Pain score(efficacy indicator);Intraoperative blood loss;Intraoperative blood transfusion rate;Incidence of device defect;System repairable failure rate;System serious failure rate;Postoperative complication rate;Postoperative readmission rate;Postoperative reoperation rate;Postoperative mortality;Device-related adverse events and serious adverse events;Adverse events and serious adverse events(safety indicator); | — |
Countries
China
Contacts
Public ContactYe Dingwei
Affiliated Cancer Hospital of Fudan University
Outcome results
None listed